New hope for fighting a stubborn lung bug
Disease control
ENROLLING_BY_INVITATION
This study is testing a new antibiotic called contezolid to see how well it kills a specific type of hard-to-treat bacteria in the lungs (Mycobacterium abscessus). It compares the new drug to an older one (linezolid) over 14 days in 24 patients. The main goal is to see if contezo…
Phase: PHASE2 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC